Orion Health is a global company that develops software to drive efficiency in healthcare and improve healthcare outcomes.Related video
Sponsored content: Interoperability matters
By Orion Health2017-03-20T07:00:00+00:00
Dr Amir Mehrkar – chief clinical information officer at Orion Health, and co-founder of INTEROPen and the InteropSummit – explains how organisations can benefit from better information sharing, and what senior board members can do to encourage the effective flow of data across the healthcare system.
Orion Health is a global company that develops software to drive efficiency in healthcare and improve healthcare outcomes.Latest video
Related articles
NewsPatient Safety Awards 2017 shortlist revealed
HSJ has announced those organisations and projects in the running for its prestigious annual Patient Safety Awards, which this year feature 10 new categories.
- HSJ Partners
Role of technology in care integration: watch the video
Gary Birks – general manager UK and Ireland at Orion Health – considers the role of technology in delivering integrated care, the traditional challenges in sharing information within and between organisations, and the way in which an integrated digital care record can support better information sharing.
- News
Confed chief challenges Hancock’s digital plans
Matt Hancock’s digital ambitions cannot be realised if the government continues to withhold capital funding from the service, the NHS Confederation’s chief has warned.
More HSJ Partners
- HSJ Partners
Managing demand for musculoskeletal services: watch the video
Ajai Seth, clinical chairman at Circle Integrated Care, talks about the complexities of demand for musculoskeletal services and how healthcare leaders might better address it within their areas
- HSJ Partners
Introducing digital care pathways for people with chronic conditions: watch the video
Ben Wilson, product specialist lead, Orion Health talks about how digitising pathways can improve care for people with chronic conditions, areas that have successfully introduced them and what leaders need to do to implement them
- HSJ Partners
Rheumatoid arthritis: a time to capitalise on drug cost reductions
Pfizer commissioned this article written by Dr James Galloway (JG). No honorarium was paid to JG but Pfizer funded the article’s publication and has final editorial control.
No comments yet